Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000902664-21-001431
Filing Date
2021-02-16
Accepted
2021-02-16 16:27:38
Documents
1

Document Format Files

Seq Description Document Type Size
1 ALIGOS THERAPEUTICS, INC. p21-0639sc13g.htm SC 13G 59850
  Complete submission text file 0000902664-21-001431.txt   61567
Mailing Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103
Business Address C/O DMS HOUSE, 20 GENESIS CLOSE PO BOX 2587 GEORGE TOWN, GRAND CAYMAN E9 KY1-1103 (345) 749-8643
HILLHOUSE CAPITAL ADVISORS, LTD. (Filed by) CIK: 0001762304 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13G

Mailing Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080
Business Address ONE CORPORATE DR., 2ND FLOOR SOUTH SAN FRANCISCO CA 94080 (800) 466-6059
Aligos Therapeutics, Inc. (Subject) CIK: 0001799448 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91770 | Film No.: 21639100
SIC: 2836 Biological Products, (No Diagnostic Substances)